Frankfurt - Delayed Quote • EUR REGENXBIO Inc. (RB0.F) Follow Add holdings 6.30 -0.05 (-0.79%) At close: May 9 at 8:00:14 AM GMT+2 Comparisons Indicators Technicals Corporate Events Draw List View Grid View Detach Attach No Tool Measure UNDO Redo All All Favorites Text Statistics Technicals Fibonacci Markings Lines Annotation Arrow Line Horizontal Vertical Rectangle Trend Line Measurement Line Average Line Callout Channel Check Continuous Crossline Elliott Wave Ellipse Doodle Fib Projection Fib Arc Fib Fan Fib Time Zone Focus Gann Fan Gartley Heart Pitchfork Quadrant Lines Ray Regression Line Fib Retracement Star Speed Resistance Arc Speed Resistance Line Time Cycle Tirone Levels Volume Profile Cross Magnet Clear All Drawings Restore Default Parameters Loading Chart for RB0.F 1D 5D 1M 3M 6M YTD 1Y 5Y All Date Range 1 min Recent News: RB0.F View More All News Press Releases SEC Filings REGENXBIO Announces Presentations at the American Society of Gene & Cell Therapy 28th Annual Meeting REGENXBIO to Participate in Upcoming Investor Conferences Regenxbio (RGNX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release REGENXBIO to Host Conference Call on May 12 to Discuss First Quarter 2025 Financial Results and Recent Operational Highlights Trump’s FDA Sends a Bullish Signal to Biotech Biotech stocks slide as Marks resignation seen being negative for sector Regenxbio’s DMD gene therapy drives 122.3% biomarker uptick in three-year-old REGENXBIO REPORTS POSITIVE BIOMARKER DATA FROM AFFINITY DUCHENNE® TRIAL OF RGX-202 GENE THERAPY REGENXBIO Inc. (NASDAQ:RGNX) Is About To Turn The Corner Q4 2024 Regenxbio Inc Earnings Call Regenxbio Inc (RGNX) Q4 2024 Earnings Call Highlights: Strategic Advances and Financial Resilience Related Tickers IMNM Immunome, Inc. 7.46 -3.24% IMVT Immunovant, Inc. 14.02 -1.96% AKRO Akero Therapeutics, Inc. 39.85 -5.99% GPCR Structure Therapeutics Inc. 25.57 -4.66% VKTX Viking Therapeutics, Inc. 27.55 -1.08% SMMT Summit Therapeutics Inc. 23.96 -2.80%